Spot Trading’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Spot Trading's REGN Position: Q3 2017 in Review
Spot Trading opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2017: 1,919 shares worth $858K. The stake represents 0.01% of the portfolio and ranks #1276 among its holdings. This is a return to the name: Spot Trading previously reported a position in REGN as recently as Q3 2016.
Spot Trading first reported a position in REGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.84M in Q2 2016. 605 funds tracked by Wall St. Rank hold REGN as of Q3 2017.
- Spot Trading held 1,919 shares of Regeneron Pharmaceuticals worth $858K as of Q3 2017.
- Regeneron Pharmaceuticals was a new Spot Trading position in Q3 2017.
- Regeneron Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1276 holding.
- Spot Trading first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
- Spot Trading's Regeneron Pharmaceuticals position peaked at $1.84M in Q2 2016.
- 605 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.
Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.